FWIA
DGX icon

Fort Washington Investment Advisors’s Quest Diagnostics DGX Stock Holding History

Fort Washington Investment Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.77M Sell
8,371
-91
-1% -$17.9K 0.01% 276
2026
Q1 		$1.66M Sell
8,462
-1,047
-11% -$203K 0.01% 280
2025
Q4 		$1.65M Buy
9,509
+245
+3% +$44.6K 0.01% 271
2025
Q3 		$1.77M Sell
9,264
-1,580
-15% -$280K 0.01% 262
2025
Q2 		$1.95M Buy
10,844
+34
+0.3% +$5.91K 0.01% 256
2025
Q1 		$1.83M Buy
10,810
+1,800
+20% +$296K 0.01% 256
2024
Q4 		$1.36M Buy
9,010
+622
+7% +$96.7K 0.01% 268
2024
Q3 		$1.3M Buy
8,388
+53
+0.6% +$7.92K 0.01% 271
2024
Q2 		$1.14M Sell
8,335
-178
-2% -$24.4K 0.01% 284
2024
Q1 		$1.13M Hold
8,513
– – 0.01% 285
2023
Q4 		$1.17M Hold
8,513
– – 0.01% 274
2023
Q3 		$1.04M Hold
8,513
– – 0.01% 270
2023
Q2 		$1.2M Hold
8,513
– – 0.01% 265
2023
Q1 		$1.2M Hold
8,513
– – 0.01% 263
2022
Q4 		$1.33M Hold
8,513
– – 0.01% 257
2022
Q3 		$1.04M Hold
8,513
– – 0.01% 278
2022
Q2 		$1.13M Hold
8,513
– – 0.01% 272
2022
Q1 		$1.17M Buy
8,513
+1,440
+20% +$201K 0.01% 296
2021
Q4 		$1.22M Buy
7,073
+324
+5% +$49.3K 0.01% 302
2021
Q3 		$981K Hold
6,749
– – 0.01% 316
2021
Q2 		$891K Sell
6,749
-353
-5% -$46.2K 0.01% 323
2021
Q1 		$911K Hold
7,102
– – 0.01% 321
2020
Q4 		$846K Buy
7,102
+58
+0.8% +$7.07K 0.01% 328
2020
Q3 		$806K Buy
7,044
+598
+9% +$70.7K 0.01% 327
2020
Q2 		$735K Hold
6,446
– – 0.01% 343
2020
Q1 		$518K Buy
6,446
+15
+0.2% +$1.55K 0.01% 329
2019
Q4 		$687K Buy
6,431
+476
+8% +$49.6K 0.01% 352
2019
Q3 		$637K Hold
5,955
– – 0.01% 368
2019
Q2 		$606K Hold
5,955
– – 0.01% 369
2019
Q1 		$535K Hold
5,955
– – 0.01% 381
2018
Q4 		$496K Hold
5,955
– – 0.01% 396
2018
Q3 		$643K Buy
5,955
+3,684
+162% +$404K 0.01% 392
2018
Q2 		$250K Hold
2,271
– – ﹤0.01% 507
2018
Q1 		$228K Hold
2,271
– – ﹤0.01% 538
2017
Q4 		$224K Hold
2,271
– – ﹤0.01% 568
2017
Q3 		$213K Hold
2,271
– – ﹤0.01% 495
2017
Q2 		$252K Hold
2,271
– – ﹤0.01% 459
2017
Q1 		$223K Hold
2,271
– – ﹤0.01% 462
2016
Q4 		$209K Buy
+2,271
New +$196K ﹤0.01% 463

Other funds holding DGX

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
CPC
Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return
AIM
Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
SIC
Schwartz Investment Counsel Plymouth, Michigan $3.01B AUM 27.22% 1-Year Est. Return

Fort Washington Investment Advisors's DGX Position: Q2 2026 in Review

Fort Washington Investment Advisors reduced its Quest Diagnostics (DGX) stake by 1.1% in Q2 2026, selling an estimated $17.9K and leaving 8,371 shares worth $1.77M. The position accounts for 0.01% of the portfolio, ranked #276.

Fort Washington Investment Advisors first reported a position in DGX in Q4 2016 and has held it in 39 quarters since. The position peaked at $1.95M in Q2 2025. 358 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Fort Washington Investment Advisors held 8,371 shares of Quest Diagnostics worth $1.77M as of Q2 2026.
  • Fort Washington Investment Advisors sold 91 Quest Diagnostics shares in Q2 2026, an estimated $17.9K.
  • Quest Diagnostics made up 0.01% of Fort Washington Investment Advisors's portfolio in Q2 2026, its #276 holding.
  • Fort Washington Investment Advisors first reported a position in Quest Diagnostics in Q4 2016 and has held it in 39 quarters since.
  • Fort Washington Investment Advisors's Quest Diagnostics position peaked at $1.95M in Q2 2025.
  • 358 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Fort Washington Investment Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.